|70.91|| +2.07 / +3.01%|
Auspex Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of novel medicines for the treatment of orphan diseases. Its pipeline includes product candidates to address unmet medical needs in hyperkinetic movement disorders, such as chorea associated with huntington's disease, an orphan disease, and tardive dyskinesia and tourette syndrome, subsets of either of which may be deemed to be orphan diseases, as well as other orphan indications. The company uses unique properties of deuterium to develop a pipeline of innovative drugs in several important disease areas. The company was founded by Sepehr Sarshar, Thomas G. Gant and Manouchehr M. Shahbaz on February 28, 2001 and is headquartered in La Jolla, CA.
|Pratik Shah||President & Chief Executive Officer|
|Bharat M. Chowrira||COO & Head-Business Development|
|John P. Schmid||Chief Financial Officer & Head-Investor Relations|
|Andreas Sommer||Secretary & Vice President-Research|
|David A. Stamler||Chief Medical Officer|